Kinesiophobia, Exercise Capacity, Peripheral Muscle Strength and Physical Activity in Patients with Hypertension: A Cross-Sectional Study

Year 2023, Volume: 40 Issue: 4, 715 - 716, 03.01.2024

Nihan Katayıfçı İrem Hüzmeli Dondu Iris Fatih Yalçın

Abstract

Functional limitations have recently shown in patients with hypertension. However, causes of kinesiophobia remain unknown. The aim was to compare functional exercise capacity, peripheral muscle strength, level of kinesiophobia, physical activity, fatigue, dyspnea, and quality of life in hypertension patients and healthy controls and to investigate relationship between aforementioned outcomes in patients. Fifty-six patients and 45 matched controls were included. Functional exercise capacity [6 min. walking test (6MWT)], peripheral muscle strength (Dynamometer), kinesiophobia (Tampa Scale of Kinesiophobia), physical activity level [International Physical Activity Questionnaire (IPAQ)], perception of dyspnea (Modified Medical Research Council Dyspnea scale), fatigue (Fatigue Severity scale), and quality of life (Short Form-36 questionnaire) were evaluated. Demographic characteristics were similar in patients (54.58±11.33y,35M/21F) and healthy controls (51.11±7.42y,33M/12F) (p>0.05). Peripheral muscle strength (p<0.05), 6MWT, physical activity and quality of life were significantly lower (p<0.05); level of kinesiophobia (p<0.001), perception of dyspnea (p<0.001), and fatigue (p=0.001) scores were higher in patients compared with controls. IPAQ (r=-0.556, p<0.001), quadriceps femoris (r=-0.429, p=0.001), hip flexor (r=-0.380, p=0.004), shoulder abductor (r=-0.410, p=0.002), elbow flexor (r=-0.364, p=0.006), hand-grip strength (r=-0.355, p=0.007), fatigue (r=0.434, p=0.001), SF-36 physical functioning (r=0.404, p=0.002), role limitations due to physical health (r=-0.370, p=0.005), energy/fatigue (r=-0.357, p=0.007), general health (r=-0.280, p=0.036) was related to kinesiophobia in patients. Patients had impaired functional exercise capacity, peripheral muscle strength, higher level of kinesiophobia, perception of fatigue and dyspnea, reduced physical activity level, and quality of life compared with healthy controls. In addition, a higher degree of kinesiophobia was related to physical inactivity, weakened upper and lower extremity muscle strength, fatigue, impaired quality of life in patients. Patients should be directed to cardiopulmonary rehabilitation.

Keywords

Hypertension, kinesiophobia, physical activity, exercise capacity, muscle strength

References

• 1. Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, et al. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019; 139(10):e56-e528. 10.1161/CIR.0000000000000659
• 2. Tadic M, Cuspidi C, Pencic B, Vukomanovic V, Taddei S, Grassi G, et al. Association between myocardial work and functional capacity in patients with arterial hypertension: an echocardiographic study. Blood Press. 2021; 30(3):188-195. 10.1080/08037051.2021.1902267.
• 3. Ramos RA, Guimarães FS, Cordovil I, de Sa Ferreira A. The six-minute walk distance is a marker of hemodynamic-related functional capacity in hypertension: a case-control study. Hypertens Res. 2014; 37(8):746-52. 10.1038/hr.2014.59.
• 4. Chen Y, Liu Y, Han P, Zhang H, Mei Y, Wang Y, et al. Mobility speed predicts new-onset hypertension: a longitudinal study. Blood Press Monit. 2022; 27(1):22-26.10.1097/MBP.0000000000000562.
• 5. Casillas JM, Damak S, Chauvet-Gelinier JC, Deley G, Ornetti P. Fatigue in patients with cardiovascular disease. Ann Readapt Med Phys. 2006; 49(6):309-402. 10.1016/j.annrmp.2006.04.002.
• 6. Ye R, Liu K, Zhang Z, Gong S, Chen X. Health-related quality of life of hypertension in China: a systematic review and meta-analysis. J Cardiovasc Med (Hagerstown). 2018; 19(8):430-8. 10.2459/JCM.0000000000000678.
• 7. Janusz K. Impact of kinesiophobia (fear before movement) to physical activity level in patients with artery hypertension. J Educ Health and Sport. 2015; 5(4):309-318.
• 8. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1):111-117. 10.1164/ajrccm.166.1.at1102.
• 9. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Respir Med. 1999; 14(2):270-274. 10.1034/j.1399-3003.1999.14b06.x.
• 10. Chuang ML, Lin IF, Wasserman K. The body weight-walking distance product as related to lung function, anaerobic threshold and peak VO2 in COPD patients. Respir Med. 2001; 95(7):618-626. 10.1053/rmed.2001.1115.
• 11. Bohannon RW. Reference values for extremity muscle strength obtained by hand-held dynamometry from adults aged 20 to 79 years. Arch Phys Med Rehabil. 1997; 78(1):26-32. 10.1016/s0003-9993(97)90005-8.
• 12. Schmidt RT, Toews JV. Grip strength as measured by the Jamar dynamometer. Arch Phys Med Rehabil. 1970; 51(6):321-7.
• 13. Tunca Yilmaz O, Yakut Y, Uygur F. Turkish version of the Tampa Scale for Kinesiophobia and its test-retest reliability. Turk J Physiother Rehabil. 2011; 22(1):44–49 (in Turkish).
• 14. Armutlu K, Korkmaz NC, Keser I, Sumbuloglu V, Akbiyik DI, Guney Z, Karabudak R. The validity and reliability of the Fatigue Severity Scale in Turkish multiple sclerosis patients. Int J Rehabil Res. 2007; 30(1):81-85. 10.1097/MRR.0b013e3280146ec4.
• 15. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988; 93(3):580-586. 10.1378/chest.93.3.580.
• 16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40(5):373–83. 10.1016/0021-9681(87)90171-8.
• 17. Saglam M, Arikan H, Savci S, Inal-Ince D, Bosnak-Guclu M, Karabulut E, et al. International physical activity questionnaire: reliability and validity of the Turkish version. Percept Mot Skills. 2010; 111(1):278-84. 10.2466/06.08.PMS.111.4.278-284.
• 18. Kaya BB, İçağasıoğlu A. Reliability and validity of the Turkish version of short form 36 (SF-36) in patients with rheumatoid arthritis. J Surg Med. 2018; 2(1):11-16. 10.28982/josam.368341
• 19. Park S, Han K, Lee S, Kim Y, Lee Y, Kang MW, et al. Cardiovascular or mortality risk of controlled hypertension and importance of physical activity. Heart. 2021; 107(18):1472-1479. 10.1136/heartjnl-2020-318193.
• 20. Nair SP, Ganu SS, Idariya F. Impact of kinesiophobia on physical activity in patients with arterial hypertension. Int J Health Sci Res. 2017; 7(5):170-175.
• 21. Maslow AL, Sui X, Colabianchi N, Hussey J, Blair SN. Muscular strength and incident hypertension in normotensive and prehypertensive men. Med Sci Sports Exerc. 2010; 42(2):288–295. 10.1249/MSS.0b013e3181b2f0a4.
• 22. Mallah MA, Liu M, Liu Y, Xu HF, Wu XJ, Chen XT, et al. Association of handgrip strength with the prevalence of hypertension in a Chinese Han population. Chronic Dis Transl Med. 2019; 5(2):113–121. 10.1016/j.cdtm.2019.05.004.
• 23. Eckhardt AL, Devon HA, Piano MR, Ryan CJ, Zerwic JJ. Fatigue in the presence of coronary heart disease. Nurs Res. 2014; 63(2):83-93. 10.1097/NNR.0000000000000019.
• 24. Palhares LC, Gallani MC, Gemignani T, Matos-Souza JR, Ubaid-Girioli S, Moreno H Jr, et al.Quality of life, dyspnea and ventricular function in patients with hypertension. J Adv Nurs. 2010; 66(10):2287-96. 10.1111/j.1365-2648.2010.05396.x.
• 25. Kurpaska M, Krzesiński P, Gielerak G, Uziębło-Życzkowska B, Banak M, Stańczyk A, et al.Exercise impedance cardiography reveals impaired hemodynamic responses to exercise in hypertensives with dyspnea. Hypertens Res. 2019; 42(2):211-222. 10.1038/s41440-018-0145-y.
• 26. Katzmarzyk PT, Friedenreich C, Shiroma EJ, Lee IM. Physical inactivity and non-communicable disease burden in low-income, middle-income and high-income countries. Br J Sports Med. 2022; 56(2):101-106. 10.1136/bjsports-2020-103640.
• 27. Liu X, Zhang D, Liu Y, Sun X, Han C, Wang B, et al. Dose-response association between physical activity and ıncident hypertension: a systematic review and meta-analysis of cohort studies. Hypertension. 2017; 69(5):813-820. 10.1161/HYPERTENSIONAHA.116.08994.
• 28. Durukan BN, Vardar Yagli N, Calik Kutukcu E, Sener YZ, Tokgozoglu L. Health related behaviours and physical activity level of hypertensive individuals during COVID-19 pandemic. Int J Rehabil Res. 2022; 45(2):176-183. 10.1097/MRR.0000000000000519.
• 29. Zyoud SH, Al-Jabi SW, Sweileh WM, Wildali AH, Saleem HM, Aysa HA, et al. Health-related quality of life associated with treatment adherence in patients with hypertension: a cross-sectional study. Int J Cardiol. 2013; 168(3):2981-3. 10.1016/j.ijcard.2013.04.105.
• 30. Arija V, Villalobos F, Pedret R, Vinuesa A, Jovani D, Pascual G, et al. Physical activity, cardiovascular health, quality of life and blood pressure control in hypertensive subjects: randomized clinical trial. Health Qual Life Outcomes. 2018; 16(1):184. 10.1186/s12955-018-1008-6.